3:21 PM
 | 
Mar 08, 2017
 |  BC Extra  |  Financial News

Spero raises $51.7M in series C

Anti-infective play Spero Therapeutics LLC (Cambridge, Mass.) raised $51.7 million in a series C round led by new investor GV. Also participating were new...

Read the full 101 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >